Endometrial Cancer Vaginal Fluid Specimen Collection Study

Part of paid clinical trials in Murfreesboro, Tennessee.

Sponsor
Exact Sciences Corporation
Study ID
NCT07544680
Status
Recruiting
Apply to this trial

Conditions

  • Abnormal Uterine Bleeding (AUB)
  • Atypical Endometrial Hyperplasia
  • Endometrial Cancer
  • Endometrial Hyperplasia With Atypia
  • Endometrial Intraepithelial Neoplasia

Eligibility Criteria

Sex
FEMALE
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Study Details

This is a multicenter, prospective, specimen collection study for development and evaluation of tests used to detect endometrial cancer, other cancers, or their causes.

Key Dates

Start date
Mar 10, 2026
Status verified
Apr 2026
Primary completion
Apr 24, 2028
Completion
Apr 24, 2028

Study Design

Enrollment
4,200 participants (estimated)

Arms

  • Arm: Cohort 1
    Participants undergoing clinical evaluation for AUB
  • Arm: Cohort 2
    Participants diagnosed with EC or AEH/EIN

Primary Outcome Measure

Collection of clinically characterized vaginal fluid specimens [ Time Frame: Within 90 days of enrollment. ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
Murfreesboro Medical ClinicMurfreesboroTennessee37130
Miles Guy
[email protected]
615-410-3460
Brad Chesney, MD (PRINCIPAL_INVESTIGATOR)

Find similar trials in Murfreesboro, TN

By condition
Endometrial cancer
By specialty
OncologyGynecologic oncologyWomen's health
By research site
Murfreesboro Medical Clinic· Murfreesboro, TN

Related Studies